Affiliation:
1. Department of Cancer, Immunology and Infectious Diseases, Pfizer Central Research, Groton, CT 06340
Abstract
AbstractIn response to LPS, peritoneal macrophages produce IL-1, but, for the most part, newly synthesized cytokine molecules remain cell associated. Externalization and proteolytic processing of pro-IL-1β can be initiated by extracellular ATP. In this study, kinetics and inhibitor sensitivity of the stimulus-coupled mechanism were investigated with [35S]methionine-labeled macrophages. Optimal ATP concentrations required to promote cytokine post-translational processing suggest the involvement of a P2Z type of receptor. Proteolysis of pro-IL-1β initiates within 7.5 min of ATP addition; 17-kDa mature IL-1β is observed first intracellularly and subsequently extracellularly. In contrast, ATP-treated cells do not contain 17-kDa IL-1α. Macrophages exposed to ATP continuously or only for a 15-min pulse release IL-1α, IL-1β, and lactate dehydrogenase (LDH). Proteolytic maturation of IL-1β exceeds that of IL-1α in both formats, but pulsed cells process the externalized cytokines more efficiently. Ethacrynic acid and DIDS (4,4′-diisothiocyanato-stilbene-2,2′-disulfonic acid) block ATP-induced proteolysis of pro-IL-1β and prevent release of pro-IL-1α/β and LDH; they do not inhibit ATP-induced K+ (86Rb+) efflux. Ethacrynic acid inhibits release of both forms of IL-1 with a similar concentration dependence; within the arrested cells, procytokines accumulate in a Triton-insoluble fraction. An IL-1β-converting enzyme inhibitor blocks proteolysis of IL-1β, but it does not prevent release of pro-IL-1α, pro-IL-1β, or LDH. These results indicate that ATP stimulates externalization of both IL-1α and IL-1β. The ATP-induced cytokine release mechanism is accompanied by cell death and requires activity of an anion transport inhibitor-sensitive component, but this pathway operates independently of cytokine proteolytic processing.
Publisher
The American Association of Immunologists
Subject
Immunology,Immunology and Allergy
Reference55 articles.
1. Dinarello, C. A.. 1996. Biologic basis for interleukin-1 in disease. Blood 87: 2095
2. Smith, J. W., W. J. Urba, B. D. Curti, L. J. Elwood, R. G. Steis, J. E. Janik, W. H. Sharfman, L. L. Miller, R. G. Fenton, K. C. Conlon, M. Sznol, S. P. Creekmore, N. F. Wells, F. W. Ruscetti, J. R. Keller, K. Hestdal, M. Shimizu, J. Rossio, W. G. Alvord, J. J. Oppenheim, D. L. Longo. 1992. The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies. J. Clin. Oncol. 10: 1141
3. Fischer, E., M. A. Marano, A. E. Barber, A. Hudson, K. Lee, C. S. Rock, A. S. Hawes, R. C. Thompson, T. J. Hayes, T. C. Anderson, W. R. Benjamin, S. F. Lowry, L. L. Moldawer. 1991. Comparison between effects of interleukin-1α administration and sublethal endotoxemia in primates. Am. J. Physiol. 261: R442
4. Pettipher, E. R., G. A. Higgs, B. Henderson. 1986. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc. Natl. Acad. Sci. USA 83: 8749
5. Van de Loo, F. A., O. J. Arntz, I. G. Otterness, W. B. van den Berg. 1992. Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis. J. Rheumatol. 19: 348
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献